SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home ▸ Press Kit
Essential resources, including the corporate fact sheet, the ESG report, and other collaterals offering a comprehensive overview of the company.
Syngene has taken significant strides to embed sustainability into its operations. At Syngene, we believe that scientific innovation and environmental responsibility go hand-in-hand. Over the past year, we sourced 92% of our electricity from renewable sources, reduced freshwater consumption by 64%, and continued to maintain zero waste to landfill across all our campuses. A major milestone was the validation of our near-term greenhouse gas (GHG) reduction targets by the Science Based Targets initiative (SBTi). We are now working towards a 54.6% reduction in Scope 1 and 2 emissions by 2033.
© 2025. Syngene International Limited